Relation between plasma concentration and therapeutic efficacy of a new anti-inflammatory compound, benoxaprofen (LRCL 3794) in rats with adjuvant-induced arthritis
- 1 September 1977
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 29 (1) , 371-372
- https://doi.org/10.1111/j.2042-7158.1977.tb11339.x
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- The pharmacology of benoxaprofen (2-[4-chlorophenyl]-α-methyl-5-benzoxazole acetic acid), LRCL 3794, a new compound with anti-inflammatory activity apparently unrelated to inhibition of prostaglandin synthesisJournal of Pharmacy and Pharmacology, 1977
- 2-Aryl-5-benzoxazolealkanoic acid derivatives with notable antiinflammatory activityJournal of Medicinal Chemistry, 1975
- Species differences in the albumin binding of 2,4,6-trinitrobenzaldehyde, chlorophenoxyacetic acids, 2-(4′-hydroxybenzeneazo)benzoic acid and some other acidic drugs—the unique behavior of rat plasma albuminBiochemical Pharmacology, 1969
- Serum protein alterations in adjuvant-induced arthritisCanadian Journal of Biochemistry, 1968
- CHEMOTHERAPY OF ARTHRITIS INDUCED IN RATS BY MYCOBACTERIAL ADJUVANTBritish Journal of Pharmacology and Chemotherapy, 1963